• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine.

作者信息

Schnuelle Peter, Kölling Sebastian, Müller Alexander, Schmitt Wilhelm H

机构信息

Center for Renal Diseases Weinheim, Weinheim, Germany.

出版信息

Clin Kidney J. 2021 Dec 23;15(3):584-586. doi: 10.1093/ckj/sfab289. eCollection 2022 Mar.

DOI:10.1093/ckj/sfab289
PMID:35211315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8862050/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bbc/8862050/cdc5a917b514/sfab289fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bbc/8862050/cdc5a917b514/sfab289fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bbc/8862050/cdc5a917b514/sfab289fig1.jpg

相似文献

1
Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine.肾结节病患者短期中断二线霉酚酸治疗后，对SARS-CoV-2信使核糖核酸疫苗产生了显著的抗体反应。
Clin Kidney J. 2021 Dec 23;15(3):584-586. doi: 10.1093/ckj/sfab289. eCollection 2022 Mar.
2
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
3
Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response.评价三种抗 SARS-CoV-2 血清学免疫分析方法在疫苗接种后的反应。
J Appl Lab Med. 2022 Jan 5;7(1):57-65. doi: 10.1093/jalm/jfab087.
4
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.维持性血液透析或腹膜透析患者接种第三剂 BNT162b2 疫苗后的 SARS-CoV-2 抗体反应。
Am J Kidney Dis. 2022 Feb;79(2):185-192.e1. doi: 10.1053/j.ajkd.2021.08.005. Epub 2021 Sep 8.
5
Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.BNT162b2 mRNA COVID-19 疫苗的抗体反应动力学：7 个月随访研究。
Medicina (Kaunas). 2021 Dec 5;57(12):1330. doi: 10.3390/medicina57121330.
6
Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals.在血清阳性和血清阴性个体中接种 SARS-CoV-2 mRNA 疫苗期间的体液免疫反应。
BMC Med. 2021 Jul 26;19(1):169. doi: 10.1186/s12916-021-02055-9.
7
Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.抗严重急性呼吸综合征冠状病毒 2 信使 RNA 疫苗在接受抗癌药物治疗的晚期肺癌患者中的短期安全性：一项多中心、前瞻性、观察性研究。
Thorac Cancer. 2022 Feb;13(3):453-459. doi: 10.1111/1759-7714.14281. Epub 2021 Dec 28.
8
Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study.BNT162b2 mRNA COVID-19 疫苗在有或无 SARS-CoV-2 既往感染的医护人员队列中诱导的抗体反应：一项前瞻性研究。
Clin Microbiol Infect. 2021 Dec;27(12):1845-1850. doi: 10.1016/j.cmi.2021.07.024. Epub 2021 Jul 28.
9
[Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].[既往感染过新冠病毒与未感染过新冠病毒的医护人员接种两剂新冠病毒灭活疫苗后的抗体反应：一项前瞻性观察研究]
Mikrobiyol Bul. 2022 Jan;56(1):36-48. doi: 10.5578/mb.20229904.
10
Comparison of antibody response to two different mRNA Covid-19 vaccines in patients on hemodialysis.血液透析患者对两种不同的 mRNA COVID-19 疫苗的抗体反应比较。
J Nephrol. 2022 Jan;35(1):143-151. doi: 10.1007/s40620-021-01195-8. Epub 2022 Jan 3.

引用本文的文献

1
The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination.鞘氨醇-1-磷酸受体调节剂对 COVID-19 和 SARS-CoV-2 疫苗接种的影响。
Mult Scler Relat Disord. 2023 Jan;69:104425. doi: 10.1016/j.msard.2022.104425. Epub 2022 Nov 22.
2
SARS-CoV-2 Vaccination in Kidney Transplant Recipients-Stratified Analysis of the Humoral Immune Response.肾移植受者中的2019冠状病毒病疫苗接种——体液免疫反应的分层分析
Transplant Direct. 2022 Oct 14;8(11):e1384. doi: 10.1097/TXD.0000000000001384. eCollection 2022 Nov.

本文引用的文献

1
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.霉酚酸临时停药增强风湿性和肌肉骨骼疾病患者对SARS-CoV-2疫苗的体液免疫反应：病例系列
Ann Rheum Dis. 2022 Feb;81(2):293-295. doi: 10.1136/annrheumdis-2021-221252. Epub 2021 Sep 23.
2
Challenges of Sarcoidosis and Its Management.结节病的挑战及其管理
N Engl J Med. 2021 Sep 9;385(11):1018-1032. doi: 10.1056/NEJMra2101555.
3
The association of COVID-19 antibody with in-hospital outcomes in COVID-19 infected patients.
新型冠状病毒感染患者的院内结局与新型冠状病毒抗体的相关性。
J Med Virol. 2021 Dec;93(12):6841-6844. doi: 10.1002/jmv.27260. Epub 2021 Aug 12.
4
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.肾移植患者与透析患者对SARS-CoV-2疫苗的体液免疫和细胞免疫：一项使用mRNA-1273或BNT162b2 mRNA疫苗的前瞻性多中心观察性研究。
Lancet Reg Health Eur. 2021 Oct;9:100178. doi: 10.1016/j.lanepe.2021.100178. Epub 2021 Jul 23.
5
Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people.法国第一波疫情期间慢性病、健康状况与新冠病毒相关住院及院内死亡风险：一项针对6600万人的队列研究
Lancet Reg Health Eur. 2021 Sep;8:100158. doi: 10.1016/j.lanepe.2021.100158. Epub 2021 Jul 16.
6
Evidence for antibody as a protective correlate for COVID-19 vaccines.针对 COVID-19 疫苗，抗体作为一种保护相关因素的证据。
Vaccine. 2021 Jul 22;39(32):4423-4428. doi: 10.1016/j.vaccine.2021.05.063. Epub 2021 May 24.
7
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗的高抗体反应。
Ann Rheum Dis. 2021 Oct;80(10):1351-1352. doi: 10.1136/annrheumdis-2021-220656. Epub 2021 May 24.
8
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
9
Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients.肾结节病：47例患者的临床、实验室及组织学表现与转归
Medicine (Baltimore). 2009 Mar;88(2):98-106. doi: 10.1097/MD.0b013e31819de50f.